换一批A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer.
第一作者：
I,Garrido-Laguna
第一单位：
Department of Internal Medicine (Division of Oncology), Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA, ignacio.garrido-laguna@hci.utah.edu.
作者：
医学主题词
成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿扎胞苷(Azacitidine);结直肠肿瘤(Colorectal Neoplasms);DNA甲基化(DNA Methylation);DNA修饰甲基酶类(DNA Modification Methylases);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);肿瘤转移(Neoplasm Metastasis);原癌基因蛋白质类(Proto-Oncogene Proteins);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));ras蛋白质类(ras Proteins)
DOI
10.1007/s10637-013-9947-6
PMID
23504398
发布时间
2022-04-08
- 浏览34
Investigational new drugs
1257-64页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
